Company intelligence / Profile preview

PureOlive Extracts

Nîmes, Occitanie, France

Ownership: Private
Development stage: Other

Overview

PureOlive is a French biotechnology company specializing in the extraction and stabilization of high-purity polyphenols from olives, specifically focusing on hydroxytyrosol. The company utilizes proprietary extraction technologies to produce standardized ingredients for the nutraceutical, cosmeceutical, and pharmaceutical industries. Their primary products target cardiovascular health, metabolic wellness, and healthy aging by leveraging the antioxidant and anti-inflammatory properties of olive-derived compounds. PureOlive's research emphasizes the prevention of LDL oxidation and the support of mitochondrial health.

Therapeutic areas: CardiovascularMetabolic Disorders
Modalities: Small molecule
Industry: Chemicals & Materials

Beyond the preview

Go deeper on PureOlive Extracts.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PureOlive Extracts.

Explore the full profile